Analysis on the growth of China's import and export of traditional Chinese medicine to the Middle East in 2011

In 2011, China's import and export volume of traditional Chinese medicine to the Middle East reached 36.06 million US dollars, an increase of 73% year-on-year, far higher than the overall growth rate of traditional Chinese medicine trade in the same period (35%) Among them, China's export of traditional Chinese medicine to the Middle East was 21.08 million US dollars, an increase of 7% year-on-year; while in 2011, China's import of herbal medicine from the region reached 14.98 million US dollars, an increase of 1170% year-on-year At present, the main botanical drugs imported from the Middle East include frankincense, myrrh, blood scorpion, essential oil (including extract and pure oil) of non citrus fruits and cumingzi Due to the large increase of domestic demand for liquorice juice and extract, the products originally dominated by Turkmenistan and the United States have been unable to meet the market demand In 2011, some foreign-funded enterprises imported a large number of liquorice extract products from the United Arab Emirates, which led to a significant increase in China's import of botanical drugs from the Middle East in 2011 The largest export of Chinese herbal medicine to the Middle East is extract, accounting for 46% of the total export of Chinese herbal medicine to the Middle East; the fastest growing export is health products, while the export of herbal pieces has a certain decline compared with last year At present, the main export commodities of Chinese medicine to the Middle East include cool oil, oil of crow grass, plant juice and extract, beeswax, turmeric, royal jelly preparation and bee pollen, etc Among them, the products with rapid year-on-year growth in export volume are mainly natural or synthetic glycosides and their salts, and the oil of Kadsura; the products with large year-on-year decline in export volume are mainly "natural or synthetic glycosides and their salts" and Chinese patent medicines (with fixed dose or retail packaging); the varieties with large year-on-year increase in average export price are mainly turmeric and bee pollen, and the average export price is lower than that of the previous year The varieties with larger slip are mainly natural or synthetic glycosides and their salts, plant juices and extracts In 2011, there were 212 Chinese medicine export enterprises to the Middle East, 156 of which were private enterprises, with an export volume of US $13.91 million, a year-on-year increase of 37%, accounting for 66% of the total export volume of Chinese medicine to the Middle East At present, Fujian, Yunnan and Zhejiang are the main export provinces of traditional Chinese medicine to the Middle East, while Jiangsu, Yunnan and Zhejiang are the provinces with rapid export growth.